Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma - Contacts and Locations

Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00072397. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00072397

Locations


United States, Massachusetts
	Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
	Boston, Massachusetts, United States, 02115

United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Lee M. Krug, MD	Memorial Sloan-Kettering Cancer Center